Cortical responses to amphetamine exposure studied by pCASL MRI and pharmacokinetic/pharmacodynamic dose modeling

NeuroImage

Volumn 68, Issue , 2013, Pages 75-82

  Nordin, Love Engström ^a,b   Li, Tie Qiang ^a,b   Brogren, Jacob ^c   Johansson, Patrik ^c   Sjögren, Niclas ^c   Hannesdottir, Kristin ^c   Björk, Charlotta ^c   Segerdahl, Märta ^b,c   Wang, Danny J J ^d   Julin, Per ^c,e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DANDERYD HOSPITAL   (Sweden)

Author keywords

Amphetamine; CBF; PCASL; Perfusion; Pharmacodynamic; Pharmacological MRI

Indexed keywords

AMPHETAMINE;

ADULT; ARTERIAL SPIN LABELING; ARTICLE; BASAL GANGLION; BLOOD SAMPLING; BRAIN BLOOD FLOW; BRAIN PERFUSION; CONTROLLED STUDY; FRONTAL CORTEX; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; INSULA; MALE; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPIN LABELING;

ADULT; AMPHETAMINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DOUBLE-BLIND METHOD; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; SPIN LABELS; YOUNG ADULT;

EID: 84871650158     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.11.035     Document Type: Article

References (29)

1. Bruns A., Kunnecke B., Risterucci C., Moreau J.L., von Kienlin M. Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats. Magn. Reson. Med. 2009, 61:1451-1458.
2. Chen Y., Wan H.I., O'Reardon J.P., Korczykowski M., Wang Z., Wang J., Detre J.A. ASL phMRI after a single dose of oral citalopram. ISMRM ESMRMB Joint Anual Meeting, Stockholm 2010.
3. Chen Y., Wan H.I., O'Reardon J.P., Wang D.J., Wang Z., Korczykowski M., Detre J.A. Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram. Clin. Pharmacol. Ther. 2011, 89:251-258.
4. Chen, Y., Wan, H.I., O'Reardon, J.P., Wang, D.J., Wang, Z., Korczykowski, M., Detre, J.A. Quantification of cerebral blood flow as biomarker of drug effect: arterial spin labeling phMRI after a single dose of oral citalopram. Clin. Pharmacol. Ther. 89, 251-258.
5. Dai W., Garcia D., de Bazelaire C., Alsop D.C. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn. Reson. Med. 2008, 60:1488-1497.
6. Dayneka N.L., Garg V., Jusko W.J. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 1993, 21:457-478.
7. Devous M.D., Trivedi M.H., Rush A.J. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers. J. Nucl. Med. 2001, 42:535-542.
8. Grichisch Y., Cavusoglu M., Preissl H., Uludag K., Hallschmid M., Birbaumer N., Haring H.U., Fritsche A., Veit R. Differential effects of intranasal insulin and caffeine on cerebral blood flow. Hum. Brain Mapp. 2012, 33:280-287.
9. Kahn D.A., Prohovnik I., Lucas L.R., Sackeim H.A. Dissociated effects of amphetamine on arousal and cortical blood flow in humans. Biol. Psychiatry 1989, 25:755-767.
10. Khalili-Mahani N., van Osch M.J., Baerends E., Soeter R.P., de Kam M., Zoethout R.W., Dahan A., van Buchem M.A., van Gerven J.M., Rombouts S.A. Pseudocontinuous arterial spin labeling reveals dissociable effects of morphine and alcohol on regional cerebral blood flow. J. Cereb. Blood Flow Metab. 2011, 31:1321-1333.
11. Li T.Q., Guang Chen Z., Ostergaard L., Hindmarsh T., Moseley M.E. Quantification of cerebral blood flow by bolus tracking and artery spin tagging methods. Magn. Reson. Imaging 2000, 18:503-512.
12. Li T.Q., Haefelin T.N., Chan B., Kastrup A., Jonsson T., Glover G.H., Moseley M.E. Assessment of hemodynamic response during focal neural activity in human using bolus tracking, arterial spin labeling and BOLD techniques. Neuroimage 2000, 442-451.
13. Li T.Q., Kastrup A., Moseley M.E., Glover G.H. Changes in baseline cerebral blood flow in humans do not influence regional cerebral blood flow response to photic stimulation. J. Magn. Reson. Imaging 2000, 12:757-762.
14. Li T.Q., Jonsson T., Wiberg M., Wang J. Inter- and intra-subject variability of CBF measurements using PCASL method. ISMRM ESMRMB Joint Annual Meeting, Stockholm 2010, 2010.
15. Luh W.M., Li T.Q., Wong E.C., Bandettini P.A. Pseudo-continuous arterial spin labeling at 7T. Proc Int Soc Magn Reson Med, Toronto 2008.
16. Luh W.M., Talagala S.L., Li T.Q., Bandettini P.A. Pseudo-continuous arterial spin labeling at 7 T for human brain: estimation and correction for off-resonance effects using a Prescan. Magn. Reson. Med. 2012, 10.1002/mrm.24266.
17. Mathew R.J., Wilson W.H. Dextroamphetamine-induced changes in regional cerebral blood flow. Psychopharmacology (Berl) 1985, 87:298-302.
18. Price J.C., Drevets W.C., Ruszkiewicz J., Greer P.J., Villemagne V.L., Xu L., Mazumdar S., Cantwell M.N., Mathis C.A. Sequential H(2)(15)O PET studies in baboons: before and after amphetamine. J. Nucl. Med. 2002, 43:1090-1100.
19. Ren J., Xu H., Choi J.K., Jenkins B.G., Chen Y.I. Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses. Synapse 2009, 63:764-772.
20. Rose S.E., Janke A.L., Strudwick M.W., McMahon K.L., Chalk J.B., Snyder P., De Zubicaray G.I. Assessment of dynamic susceptibility contrast cerebral blood flow response to amphetamine challenge: a human pharmacological magnetic resonance imaging study at 1.5 and 4T. Magn. Reson. Med. 2006, 55:9-15.
21. Savic R.M., Jonker D.M., Kerbusch T., Karlsson M.O. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J. Pharmacokinet. Pharmacodyn. 2007, 34:711-726.
22. Schouw M.L., Gevers S., Caan M.W., Majoie C.B., Booij J., Nederveen A.J., Reneman L. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI. Eur. Neuropsychopharmacol. 2011, 22(8):537-545. (August).
23. Silva A.C., Zhang W., Williams D.S., Koretsky A.P. Multi-slice MRI of rat brain perfusion during amphetamine stimulation using arterial spin labeling. Magn. Reson. Med. 1995, 33:209-214.
24. Talagala S.L., Li T.Q., Merkle H., Wang S., Bodurka J., van Gelderen P., Comparison of continuous arterial spin labeling perfusion MRI at 7T and 3T. Proc Int Soc Magn Reson Med, Toronto 2008.
25. Vollenweider F.X., Maguire R.P., Leenders K.L., Mathys K., Angst J. Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Psychiatry Res. 1998, 83:149-162.
26. Wang Z., Aguirre G.K., Rao H., Wang J., Fernandez-Seara M.A., Childress A.R., Detre J.A. Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn. Reson. Imaging 2008, 26:261-269.
27. Wang D.J., Chen Y., Fernandez-Seara M.A., Detre J.A. Potentials and challenges for arterial spin labeling in pharmacological magnetic resonance imaging. J. Pharmacol. Exp. Ther. 2011, 337:359-366.
28. Wolkin A., Angrist B., Wolf A., Brodie J., Wolkin B., Jaeger J., Cancro R., Rotrosen J. Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology (Berl) 1987, 92:241-246.
29. Wu W.C., Fernandez-Seara M., Detre J.A., Wehrli F.W., Wang J. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn. Reson. Med. 2007, 58:1020-1027.